Home2026-03-06T16:27:54+00:00

We are helping to accelerate accessible positive health outcomes globally by harnessing the power of IgY antibodies.

We are leading the way in developing and commercializing novel IgY antibody-based solutions that will enable improvements in healthcare, food nutrition and agriculture.

Capabilities

We are pioneers in the extraction and purification of IgY antibodies. Our proprietary MASON Extraction Methodology™ makes it possible to produce IgY antibodies at pharmaceutical purity and at commercial scale. Our scientific team is empowered to develop specific antibodies, targeting some of the greatest health challenges of the twenty-first century.

Capabilities

We are pioneers in the extraction and purification of IgY antibodies. Our proprietary MASON Extraction Methodology™ makes it possible to produce IgY antibodies at pharmaceutical purity and at commercial scale. Our scientific team is empowered to develop specific antibodies, targeting some of the greatest health challenges of the twenty-first century.

Focus Areas

Human Therapeutics

Learn about our pipeline of pharmaceutical and nutraceutical solutions to tackle human health challenges.

Animal Health

Learn how we are protecting food supplies in agricultural sectors by tackling the high incidence of animal disease.

Nutraceuticals

The first and only cost-effective purified non-specific IgY protein antibodies offering consumer supplement brands strong differentiation and leadership in the immune and gut health category.

Partner With Us

Our pipeline of products are at various stages of development. We welcome the opportunity to build long term relationships with like-minded investors and partners to advance the vision of delivering a new generation of cost-effective IgY-based therapeutics targeting our most pressing health challenges. 

Partner With Us

Our pipeline of products are at various stages of development. We welcome the opportunity to build long term relationships with like-minded investors and partners to advance the vision of delivering a new generation of cost-effective IgY-based therapeutics targeting our most pressing health challenges. 

Articles

Articles

Go to Top